EXPORT LIST RSS ?
rberney's bookmarks matching tag ly33
 
Number of articles per page:
10 | 25 | 50 | 100
 
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.
John D Bradley et al.
The Journal of rheumatology. 32 (3), 417-23 (Mar 2005)
info:pmid/15742431
Posted by rberney to ly33 splaw arthritis inhibitor on Mon Jun 19 2006 at 05:08 UTC | info | related

<< Prev 0      Showing entries 1 to 1 of 1 total      Next 0 >>